Yokoyama Y, Nimura Y, Nagino M. Advances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategies. Surg Today. 2009;39:466–75.

Article  PubMed  Google Scholar 

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic adenocarcinoma, Version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15:1028–61.

Article  PubMed  Google Scholar 

Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the dutch randomized PREOPANC trial. J Clin Oncol. 2022;40:1220–30.

Article  CAS  PubMed  Google Scholar 

Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18:2–11.

Article  PubMed  Google Scholar 

Ushida Y, Inoue Y, Ito H, Oba A, Mise Y, Ono Y, et al. High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment. Pancreatology. 2021;21:130–7.

Article  CAS  PubMed  Google Scholar 

Kobayashi R, Uehara K, Ebata T, Yatsuya H, Li Y, Hida K, et al. A comparison of the diagnostic ability of 1-mm computed tomography and 3-mm magnetic resonance imaging for detecting lateral pelvic lymph node metastases from rectal cancer. Surg Today. 2025. https://doi.org/10.1007/s00595-025-03018-w.

Article  PubMed  Google Scholar 

Oba T, Maeno K, Iji R, Kiyosawa N, Park Y, Morikawa H, et al. Utility of contrast-enhanced magnetic resonance imaging for planning of surgical procedure in Paget’s disease of the breast. Surg Today. 2025. https://doi.org/10.1007/s00595-025-03016-y.

Article  PubMed  Google Scholar 

Schmid-Tannwald C, Oto A, Reiser MF, Zech CJ. Diffusion-weighted MRI of the abdomen: current value in clinical routine. J Magn Reson Imaging. 2013;37:35–47.

Article  PubMed  Google Scholar 

Dunet V, Halkic N, Sempoux C, Demartines N, Montemurro M, Prior JO, et al. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma. Eur Radiol. 2021;31:992–1001.

Article  PubMed  Google Scholar 

Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, et al. Multi-institutional validation study of the American Joint Commission on Cancer (8th Edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg. 2017;265:185–91.

Article  PubMed  Google Scholar 

Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388:248–57.

Article  CAS  PubMed  Google Scholar 

Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310:1473–81.

Article  CAS  PubMed  Google Scholar 

Uwagawa T, Sakamoto T, Yasuda J, Shiozaki H, Furukawa K, Onda S, et al. Phase II study of adjuvant chemotherapy with gemcitabine and nafamostat mesilate for pancreatic cancer. Pancreas. 2021;50:313–6.

Article  CAS  PubMed  Google Scholar 

Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691–703.

Article  Google Scholar 

Uwagawa T, Sakamoto T, Gocho T, Shiba H, Onda S, Yasuda J, et al. Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer. PLoS ONE. 2022;17:e0267623.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aoki T, Nishida N, Ueshima K, Morita M, Chishina H, Takita M, et al. Higher enhancement intrahepatic nodules on the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI as a poor responsive marker of anti-PD-1/PD-L1 monotherapy for unresectable hepatocellular carcinoma. Liver Cancer. 2021;10:615–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miao H, Fukatsu H, Ishigaki T. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol. 2007;61:297–302.

Article  PubMed  Google Scholar 

Matsuoka A, Minato M, Harada M, Kubo H, Bandou Y, Tangoku A, et al. Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med. 2008;26:15–20.

Article  PubMed  Google Scholar 

Mowbray NG, Griffith D, Hammoda M, Shingler G, Kambal A, Al-Sarireh B. A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection. HPB (Oxford). 2018;20:379–84.

Article  PubMed  Google Scholar 

Shirai Y, Shiba H, Sakamoto T, Horiuchi T, Haruki K, Fujiwara Y, et al. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection. Surgery. 2015;158:360–5.

Article  PubMed  Google Scholar 

Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98:268–74.

Article  CAS  PubMed  Google Scholar 

Proctor MJ, Morrison DS, Talwar D, Balmer SM, O’Reilly DS, Foulis AK, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a glasgow inflammation outcome study. Br J Cancer. 2011;104:726–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sonohara F, Yamada S, Kurimoto K, Inokawa Y, Takami H, Hayashi M, et al. Age-related differences in the prognosis of pancreatic cancer according to perioperative systemic therapy. Pancreas. 2021;50:37–46.

Article  PubMed  Google Scholar 

Weir CB, Jan A. BMI Classification Percentile And Cut Off Points. StatPearls Publishing LLC.; 2025.

Sierzega M, Lenart M, Rutkowska M, Surman M, Mytar B, Matyja A, et al. Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer. Ann Surg Oncol. 2017;24:808–15.

Article  PubMed  Google Scholar 

Mitsunaga S, Hasebe T, Iwasaki M, Kinoshita T, Ochiai A, Shimizu N. Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci. 2005;96:858–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartwig W, Strobel O, Hinz U, Fritz S, Hackert T, Roth C, et al. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol. 2013;20:2188–96.

Article  PubMed  Google Scholar 

Shirai Y, Onda S, Tanji Y, Hamura R, Matsumoto M, Yanagaki M, et al. Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer. Surg Oncol. 2023;51:101998.

Article  PubMed  Google Scholar 

Oba A, Inoue Y, Ono Y, Irie S, Sato T, Mise Y, et al. Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Langenbeck’s Arch Surg. 2020;405:35–41.

Article  Google Scholar 

Matsumoto I, Murakami Y, Shinzeki M, Asari S, Goto T, Tani M, et al. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: a multi-center retrospective study. Pancreatology. 2015;15:674–80.

Article  PubMed  Google Scholar 

Kurosawa J, Tawada K, Mikata R, Ishihara T, Tsuyuguchi T, Saito M, et al. Prognostic relevance of apparent diffusion coefficient obtained by diffusion-weighted MRI in pancreatic cancer. J Magn Reson Imaging. 2015;42:1532–7.

Article  PubMed  Google Scholar 

Jeon SK, Jang JY, Kwon W, Kim H, Han Y, Kim D, et al. Diffusion-weighted MR imaging in pancreatic ductal adenocarcinoma: prediction of next-generation sequencing-based tumor cellularity and prognosis after surgical resection. Abdom Radiol (NY). 2021;46:4787–99.

Article  PubMed  Google Scholar 

Hayano K, Miura F, Amano H, Toyota N, Wada K, Kato K, et al. Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients. J Hepatobiliary Pancreat Sci. 2013;20:243–8.

Article